Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7T9Y

Co-crystal structure of SARS-CoV-2 Mpro C145A with substrate peptide 8/9

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU MICROMAX-007 HF
Temperature [K]100
Detector technologyPIXEL
Collection date2021-05-17
DetectorRIGAKU HyPix-6000HE
Wavelength(s)1.54178
Spacegroup nameP 21 21 21
Unit cell lengths67.229, 98.870, 101.620
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution28.930 - 2.180
R-factor0.1822
Rwork0.179
R-free0.23630
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)7l0d
RMSD bond length0.003
RMSD bond angle0.577
Data reduction softwareCrysalisPro
Data scaling softwareCrysalisPro (1.19.2_4158)
Phasing softwarePHASER
Refinement softwarePHENIX (1.19.2_4158)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]28.9302.258
High resolution limit [Å]2.1802.180
Rmerge0.0870.439
Rmeas0.0950.490
Rpim0.0370.211
Number of reflections353873381
<I/σ(I)>14.333.75
Completeness [%]98.2
Redundancy6.2
CC(1/2)0.9980.897
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION29310-20 % (w/v) PEG 3350, 0.20-0.30 M NaCl, and 0.1 M Bis-Tris methane pH 5.5

222624

PDB entries from 2024-07-17

PDB statisticsPDBj update infoContact PDBjnumon